Federated Hermes
KYMR icon

Federated Hermes’s Kymera Therapeutics KYMR Stock Holding History

Federated Hermes’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.7M Sell
536,680
-227,240
-30% -$18M 0.07% 286
2025
Q4 		$59.4M Buy
763,920
+205,220
+37% +$13.9M 0.1% 236
2025
Q3 		$31.6M Buy
+558,700
New +$25.2M 0.06% 348
2025
Q1 		– Sell
-32
Closed -$1.29K – 2131
2024
Q4 		$1.29K Sell
32
-6,702
-100% -$303K ﹤0.01% 2006
2024
Q3 		$319K Buy
6,734
+7
+0.1% +$309 ﹤0.01% 1409
2024
Q2 		$201K Sell
6,727
-39
-0.6% -$1.35K ﹤0.01% 1475
2024
Q1 		$272K Buy
+6,766
New +$242K ﹤0.01% 1438

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return